JPH04279511A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH04279511A JPH04279511A JP3065405A JP6540591A JPH04279511A JP H04279511 A JPH04279511 A JP H04279511A JP 3065405 A JP3065405 A JP 3065405A JP 6540591 A JP6540591 A JP 6540591A JP H04279511 A JPH04279511 A JP H04279511A
- Authority
- JP
- Japan
- Prior art keywords
- water
- cosmetic
- extract
- japonica
- soluble solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 34
- 239000003021 water soluble solvent Substances 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 16
- 244000184734 Pyrus japonica Species 0.000 abstract description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract description 12
- 239000007787 solid Substances 0.000 abstract description 12
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 9
- 235000019441 ethanol Nutrition 0.000 abstract description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- 239000006210 lotion Substances 0.000 abstract description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 5
- 239000006071 cream Substances 0.000 abstract description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 abstract description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 abstract description 4
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 239000002453 shampoo Substances 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 33
- 238000012360 testing method Methods 0.000 description 13
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 10
- 102000003425 Tyrosinase Human genes 0.000 description 9
- 108060008724 Tyrosinase Proteins 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 244000280244 Luffa acutangula Species 0.000 description 8
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- -1 Thiol compounds Chemical class 0.000 description 7
- 241000228212 Aspergillus Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 229960001340 histamine Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 5
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 241001092459 Rubus Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- IDCBOTIENDVCBQ-UHFFFAOYSA-N TEPP Chemical compound CCOP(=O)(OCC)OP(=O)(OCC)OCC IDCBOTIENDVCBQ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 240000003307 Zinnia violacea Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000009777 vacuum freeze-drying Methods 0.000 description 2
- DENMGZODXQRYAR-UHFFFAOYSA-N 2-(dimethylamino)ethanethiol Chemical class CN(C)CCS DENMGZODXQRYAR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- 244000296825 Amygdalus nana Species 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062720 Pennisetum compressum Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 241001486544 Pyrola incarnata Species 0.000 description 1
- 241001486547 Pyrola japonica Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000208422 Rhododendron Species 0.000 description 1
- 241000605385 Ruscus Species 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 240000007267 Stephania hernandifolia Species 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical class NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、新規な化粧料に関する
。さらに詳しくは、イチヤクソウ科の植物の全草の水溶
性溶媒抽出物を有効成分として含有することを特徴とし
、安定な美白作用及び抗炎症作用を併せ持ち、かつ安全
性においても好ましいものである化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a new cosmetic composition. More specifically, it is a cosmetic that is characterized by containing a water-soluble solvent extract of the whole plant of a plant belonging to the family Alocataceae as an active ingredient, which has both stable whitening and anti-inflammatory effects, and which is also preferable in terms of safety. Regarding.
【0002】0002
【従来の技術】皮膚のしみ、そばかすなどの発生機構に
ついては不明な点もあるが、一般にはホルモンの異常や
日光からの紫外線の刺激が原因となってメラニン色素が
形成され、これが皮膚内に異常沈着するものと考えられ
ている。この様な、しみやそばかすの治療には、皮膚内
に存在するチロジナ−ゼ活性を阻害してメラニン生成を
抑制する物質、例えば、ビタミンCを大量に投与する方
法、グルタチオンを軟膏、クリ−ム、ロ−ションなどの
形態にして局所に塗布する方法などがとられている。ま
た、欧米ではハイドロキノン製剤が医薬品として用いら
れている。[Prior Art] The mechanism by which skin spots and freckles occur is still unclear, but in general, melanin pigments are formed due to hormonal abnormalities or stimulation of ultraviolet rays from sunlight, and this is caused by the formation of melanin within the skin. It is thought that it is abnormally deposited. To treat such age spots and freckles, substances that inhibit tyrosinase activity in the skin and suppress melanin production, such as large doses of vitamin C, or glutathione in ointments or creams, can be used. For example, it is applied locally in the form of a lotion or the like. Additionally, hydroquinone preparations are used as pharmaceuticals in Europe and America.
【0003】また、様々な皮膚刺激、例えば、紫外線の
作用により皮膚は炎症を起こすが、これらの炎症を抑制
するものが、抗炎症剤であり、化粧料用成分としては、
アロエ、ヘチマ等の植物抽出物、グリチルリチン、亜鉛
華等が用いられている。[0003] In addition, various skin irritations, such as the action of ultraviolet rays, cause skin inflammation, and anti-inflammatory agents suppress these inflammations.
Plant extracts such as aloe and loofah, glycyrrhizin, zinc oxide, etc. are used.
【0004】0004
【発明が解決しようとする課題】ビタミンC類は、熱、
光に対し経時的安定性が悪く、特に、水分を含む系で変
色、変臭の原因となる。一方、ハイドロキノン系は皮膚
刺激、アレルギー性等の安全性に問題があるため、使用
が制限されており、さらに、空気酸化され易いため安定
性の面においても問題がある。グルタチオン、システイ
ン等のチオ−ル化合物は異臭が強い上、酸化されやすく
効果も緩慢である。2−メルカプトエチルアミン塩、N
−(2−メルカプトエチル)ジメチルアミン塩等は、黒
色モルモットの皮膚を脱色することが知られているが、
脱色後に白班が生じやすいので、一般には使用されてい
ない。[Problem to be solved by the invention] Vitamin C
It has poor stability against light over time and causes discoloration and odor, especially in systems containing water. On the other hand, hydroquinone-based compounds have safety problems such as skin irritation and allergy, so their use is restricted, and furthermore, they are susceptible to air oxidation, which causes problems in terms of stability. Thiol compounds such as glutathione and cysteine have a strong off-flavor, are easily oxidized, and have slow effects. 2-Mercaptoethylamine salt, N
-(2-Mercaptoethyl)dimethylamine salt etc. are known to bleach the skin of black guinea pigs, but
It is not generally used because it tends to cause white spots after decolorization.
【0005】一方、美白作用及び抗炎症作用を有する成
分は前記のごとく様々なものがあるが、それらの効果を
合わせもつ化粧料を製造するためには、それらの複数の
成分をそれぞれ添加するしかなく、製品の安定性等留意
しなければならない点が多い。On the other hand, there are various ingredients that have whitening and anti-inflammatory effects as mentioned above, but in order to produce cosmetics that have both of these effects, it is necessary to add each of these ingredients. However, there are many points that must be kept in mind, such as product stability.
【0006】[0006]
【課題を解決するための手段】本発明者らは、かかる状
況を鑑み、鋭意研究を重ねた結果、イチヤクソウ科の植
物の全草の水溶性溶媒抽出物を有効成分として含有する
化粧料が、安定で良好な美白作用及び抗炎症作用を有し
、かつ安全性においても好ましいものであることを見い
出し、本発明を完成するに至った。[Means for Solving the Problems] In view of the above circumstances, the present inventors have conducted extensive research and have found that a cosmetic containing a water-soluble solvent extract of the whole plant of the Alocataceae family as an active ingredient has been developed. The present inventors have discovered that it has stable and good whitening and anti-inflammatory effects, and is also preferable in terms of safety, leading to the completion of the present invention.
【0007】本発明で使用する出発原料起源としてはい
ずれのイチヤクソウ科の植物でもよく、特に限定する必
要はない。また、出発原料起源として用いるイチヤクソ
ウ科の植物は1種でも2種以上の混合でもよい。イチヤ
クソウ科の植物とは、主に日本、朝鮮、中国等に自生し
ている多年草の植物で、例としては、イチヤクソウ(P
yrola japonica Klenze)、ベニ
バナイチヤクソウ(Pyrola incarnata
Fischer)、ジンヨウイチヤクソウ(Pyro
la renifolica Maxim.)等があげ
られる。また、これらの植物の全草の乾燥品の熱水抽出
物は強心、降圧、抗菌等の作用が知られている。[0007] The starting material used in the present invention may be any plant belonging to the family Alocataceae and is not particularly limited. Furthermore, the plants of the family Alocataceae used as the source of the starting material may be one type or a mixture of two or more types. Plants of the family Ichiyakudae are perennial plants that grow naturally in countries such as Japan, Korea, and China.
pyrola japonica Klenze), Pyrola incarnata
Fischer), Pyro
La renifolia Maxim. ) etc. In addition, hot water extracts of dried whole plants of these plants are known to have cardiotonic, antihypertensive, and antibacterial effects.
【0008】本発明で使用する水溶性溶媒とは水もしく
は水に可溶な溶媒で、例えばアルコ−ル類(メタノ−ル
、エタノ−ル、1,3−ブチレングリコール、プロピレ
ングリコール等)、アセトンなどが挙げられる。また、
本発明の植物の抽出は、これらの水溶性溶媒の1種また
は2種以上の混合溶媒を用いたものであっても良い。ま
た、加熱抽出したものであっても良いし、常温抽出した
ものであっても良い。必要に応じて、濃縮あるいは希釈
して化粧品原料として用いることが出来る。The water-soluble solvent used in the present invention is water or a water-soluble solvent, such as alcohols (methanol, ethanol, 1,3-butylene glycol, propylene glycol, etc.), acetone, etc. Examples include. Also,
The plant extraction of the present invention may be performed using one or a mixed solvent of two or more of these water-soluble solvents. Further, it may be extracted by heating or extracted at room temperature. If necessary, it can be concentrated or diluted and used as a cosmetic raw material.
【0009】本発明の化粧料には、植物の全草の水溶性
溶媒抽出物の効果を損なわない範囲内で、油脂類、ロウ
類、炭化水素類、脂肪酸類、アルコ−ル類、エステル類
、金属石鹸、界面活性剤などを原料として配合すること
ができる。The cosmetic of the present invention may contain oils and fats, waxes, hydrocarbons, fatty acids, alcohols, and esters within the range that does not impair the effects of the water-soluble solvent extract of the whole plant. , metal soap, surfactant, etc. can be blended as raw materials.
【0010】これらの基剤を原料として製造される化粧
料としては、例えば、化粧水、クリ−ム、乳液、シャン
プ−、ファンデ−ション、リップクリ−ム、口紅などが
挙げられる。Cosmetics manufactured using these bases as raw materials include, for example, lotions, creams, milky lotions, shampoos, foundations, lip balms, and lipsticks.
【0011】本発明の化粧料に用いるイチヤクソウ科の
植物の全草の水溶性溶媒抽出物の使用量は、溶媒を留去
して得られた固形分として、化粧料全体に対して0.0
1〜10重量%、好ましくは、0.1〜5.0重量%配
合するのが適当である。0.01重量%未満では十分な
効果が望めず、10重量%を越えて配合しても効果の増
強がなく不経済である。[0011] The amount of the water-soluble solvent extract of the whole plant of the Alocataceae plant used in the cosmetic of the present invention is 0.0% as a solid content obtained by distilling off the solvent based on the entire cosmetic.
It is appropriate to add 1 to 10% by weight, preferably 0.1 to 5.0% by weight. If it is less than 0.01% by weight, no sufficient effect can be expected, and if it exceeds 10% by weight, the effect will not be enhanced and it is uneconomical.
【0012】また、添加の方法については、予め加えて
おいても、製造途中で添加しても良く、作業性を考えて
、適宜選択すれば良い。[0012] Furthermore, the method of addition may be either added in advance or added during production, and may be selected as appropriate in consideration of workability.
【0013】以下に実施例を挙げて本発明を更に具体的
に説明するが、本発明は何らこれらに限定されるもので
はない。なお、実施例に示す部とは重量部を、%とは重
量%を示す。The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited thereto. In addition, the part shown in an Example shows a weight part, and % shows a weight%.
【0014】[0014]
【実施例】実施例1 イチヤクソウの全草50gを細
断し、水500mlで3時間ずつ2回加熱抽出し、残さ
を濾別する。さらに、真空凍結乾燥により濃縮すること
により抽出物10g(99%以上の固形物を含む)を得
た。[Example] Example 1 50 g of the whole plant of Ichiyakusou was shredded, heated and extracted twice with 500 ml of water for 3 hours each time, and the residue was filtered. Further, 10 g of extract (containing 99% or more solids) was obtained by concentrating by vacuum freeze-drying.
【0015】実施例2 ベニバナイチヤクソウの全草
50gを細断し、水500mlで3時間ずつ2回加熱抽
出し、残さを濾別。さらに、真空凍結乾燥により濃縮す
ることにより抽出物11g(99%以上の固形物を含む
)を得た。Example 2 50 g of the whole plant of Rhododendron japonica was shredded, heated and extracted twice with 500 ml of water for 3 hours each, and the residue was separated by filtration. Furthermore, 11 g of extract (containing 99% or more solids) was obtained by concentrating by vacuum freeze-drying.
【0016】実施例3 乾燥したジンヨウイチヤクソ
ウの全草50gを粉砕し、水−エタノ−ル混液(1:1
)500mlで5時間加熱抽出して、さらに濃縮するこ
とにより抽出物13g(99%の固形物を含む)を得た
。Example 3 50 g of the dried whole plant of Zinnia chinensis was crushed and mixed with water-ethanol mixture (1:1).
) 500ml for 5 hours and further concentrated to obtain 13g of extract (containing 99% solids).
【0017】実施例4 乾燥したイチヤクソウの全草
60gを粉砕し、エタノ−ル300mlを加え、常温で
1カ月放置する。さらに濃縮することにより抽出物14
g(99%以上の固形物を含む)を得た。Example 4 [0017] 60 g of dried whole plant of Ichiyakusou was crushed, 300 ml of ethanol was added thereto, and the mixture was left at room temperature for one month. By further concentrating extract 14
g (containing more than 99% solids) was obtained.
【0018】実施例5 乾燥したベニバナイチヤクソ
ウの葉60gを粉砕し、プロピレングリコール600m
lで3時間ずつ2回加熱抽出し、さらに濃縮することに
より抽出物20g(70%の固形物を含む)を得た。Example 5 60g of dried russet leaves were crushed and mixed with 600ml of propylene glycol.
The extract was heated and extracted twice for 3 hours each time with 20 g of extract (containing 70% solids) by further concentration.
【0019】実施例6 化粧水
(1)イチヤクソウ全草の熱水抽出物
(固形物として99%)
5.0 部(2)グリ
セリン
2.0(3)エチルアルコ−
ル
7.0(4)パラオキシ安息香酸メチル
0.05(5)ポ
リオキオシエチレン
(20)ラウリルエ−テル
0.5(6)クエン酸
0.01(7)クエン酸ナトリウム
0.1(8)香料
0
.1(9)精製水にて全量を100とする
(2)から(4)を混合して溶解する。別に成分(1)
及び(5)から(9)を混合して溶解する。ついで両者
を混合し、テトロン製布(300メッシュ)により濾過
し、製品とする。Example 6 Lotion (1) Hot water extract of whole plant of Ichiyakuso (99% as solid)
5.0 parts (2) Glycerin
2.0(3) Ethyl alcohol
le
7.0(4) Methyl paraoxybenzoate
0.05(5) Polyoxyoxyethylene (20) Lauryl ether
0.5 (6) citric acid
0.01(7) Sodium citrate
0.1 (8) Fragrance
0
.. 1(9) Make the total amount 100% with purified water. Mix and dissolve (2) to (4). Separate ingredient (1)
and (5) to (9) are mixed and dissolved. Then, both are mixed and filtered through Tetron cloth (300 mesh) to obtain a product.
【0020】実施例7 化粧水
(1)ベニバナイチヤクソウの全草の熱水抽出物
(固形物として99%)
3.0 部(2)グリセリン
2.0(3)エチルアルコ−ル
7.0(4)ポリオキオシエチレン
(20)ラウリルエ−テル
0.5(5)パラオキシ安
息香酸メチル
0.05(6)クエン酸
0.
01(7)クエン酸ナトリウム
0.1(8)香料
0.1(9)精製水にて全
量を100とする
成分(2)から(4)を混合して溶解する。別に成分(
1)及び(5)から(9)を混合して溶解する。ついで
両者を混合し、テトロン製布(300メッシュ)により
濾過し、製品とする。Example 7 Lotion (1) Hot water extract of whole plant of Safflower
(99% as solid)
3.0 parts (2) Glycerin
2.0(3) Ethyl alcohol
7.0 (4) Polyoxyethylene (20) Lauryl ether
0.5(5) Methyl paraoxybenzoate
0.05(6) citric acid
0.
01(7) Sodium citrate
0.1 (8) Fragrance
0.1 (9) Mix and dissolve components (2) to (4) to make the total amount 100 with purified water. Separately, the ingredients (
Mix and dissolve 1) and (5) to (9). Then, both are mixed and filtered through Tetron cloth (300 mesh) to obtain a product.
【0021】実施例8 クリーム
(1)ジンヨウイチヤクウの全草の熱水抽出物
(固形物として99%)
2.0 部(2)スクワラン
5.5(3)オリーブ油
3.0(4)ステアリン酸
2.0
(5)ミツロウ
2.0(6)ミ
リスチン酸オクチルドデシル
3.5(7)ポリオキシエチレン
(20)セチルエーテル
3.0(8)ベヘニルア
ルコール
1.5(9)グリセリンモノステアレート
2.5(10)1
,3−ブチレングリコール
8.5(11)パラオキシ安息香酸メチル
0.2(12)パラ
オキシ安息香酸エチル
0.05(13)香料
0.1(14)精製水にて全量を100とする成分(
2)から(9)を加熱溶解して混合し、70℃に保ち油
相とする。成分(1)及び(10)から(12)を成分
(14)に加熱溶解して混合し、75℃に保ち水相とす
る。油相に水相を加えて乳化し、成分(13)を加えて
かき混ぜながら、30℃まで冷却して製品とする。Example 8 Cream (1) Hot water extract of the whole plant of Prunus japonicus
(99% as solid)
Part 2.0 (2) Squalane
5.5(3) Olive oil
3.0(4) Stearic acid
2.0
(5) Beeswax
2.0(6) Octyldodecyl myristate
3.5 (7) Polyoxyethylene (20) Cetyl ether
3.0(8) Behenyl alcohol
1.5(9) Glycerin monostearate
2.5(10)1
,3-butylene glycol
8.5(11) Methyl paraoxybenzoate
0.2(12) Ethyl paraoxybenzoate
0.05 (13) Fragrance
0.1 (14) Ingredients whose total amount is 100 with purified water (
2) to (9) are heated and dissolved, mixed, and kept at 70°C to form an oil phase. Components (1) and (10) to (12) are heated and dissolved in component (14), mixed, and kept at 75° C. to form an aqueous phase. Add the aqueous phase to the oil phase to emulsify, add component (13), and cool to 30°C while stirring to obtain a product.
【0022】実施例9 乳液
(1)イチヤクソウの全草のエタノール抽出物
(固形分として99%)
1.0 部(2)スクワラン
5.0(3)オリーブ油
5.0(4)ホホバ油
5
.0(5)セチルアルコール
1.5(6)グリセ
リンモノステアレート
2.0(7)ポリオキシエチレン
(20)セチルエーテル
3.0(8)ポリオキシ
エチレン
(20)ソルビタンモノオレエート
2.0(9)ジプロピレングリコー
ル 1.
0(10)グリセリン
2.0(11)香
料
0.1(12)パラオキ
シ安息香酸メチル
0.2(13)精製水にて全量を100とする[製法
]成分(2)から(8)を加熱溶解して混合し、70℃
に保ち油相とする。成分(1)、(9)、(10)及び
(12)を成分(13)に加熱溶解して混合し、75℃
に保ち水相とする。油相に水相を加えて乳化分散し、成
分(11)を加えてかき混ぜながら、30℃まで冷却し
製品とする。Example 9 Emulsion (1) Ethanol extract of whole plant of Ichiyakuso
(99% as solid content)
1.0 part (2) Squalane
5.0 (3) Olive oil
5.0 (4) Jojoba oil
5
.. 0(5) Cetyl alcohol
1.5(6) Glycerin monostearate
2.0 (7) Polyoxyethylene (20) Cetyl ether
3.0 (8) Polyoxyethylene (20) Sorbitan monooleate
2.0(9) Dipropylene glycol 1.
0 (10) glycerin
2.0 (11) Fragrance
0.1(12) Methyl paraoxybenzoate
0.2 (13) Make the total amount 100% with purified water [Production method] Components (2) to (8) are dissolved and mixed by heating at 70°C.
Keep it as an oil phase. Components (1), (9), (10) and (12) are heated and dissolved in component (13), mixed, and heated to 75°C.
Maintain the aqueous phase. Add the aqueous phase to the oil phase to emulsify and disperse, add component (11), and cool to 30° C. while stirring to obtain a product.
【0023】実施例10 パック
(1)ジンヨウイチヤクソウの全草の
プロピレングリコー
ル抽出物 (固形
物として20%) 3.0 部(
2)エチルアルコール
7.5(3)1,3−ブチ
レングリコール
1.0(4)ポリビニルアルコール
10.5(5)ポリオキ
シエチレン(40)
硬化ヒマシ
油 0.5(6)
パラオキシ安息香酸メチル
0.2(7)香料
0.05(8)精製水にて全量を100とす
る
成分(1)から(8)を75℃にて加温溶解し、30℃
まで冷却し製品とする。Example 10 Pack (1) 3.0 parts of propylene glycol extract (20% as solid matter) of the whole plant of Zinnia japonica (
2) Ethyl alcohol
7.5(3) 1,3-butylene glycol
1.0(4) Polyvinyl alcohol
10.5 (5) Polyoxyethylene (40) Hydrogenated castor oil 0.5 (6)
Methyl paraoxybenzoate
0.2 (7) Fragrance
0.05 (8) Dissolve components (1) to (8) with purified water to make the total amount 100 at 75°C, and dissolve at 30°C.
Cool it until it becomes a product.
【0024】[0024]
【発明の効果】本発明のイチヤクソウ、ベニバナイチヤ
クソウまたはジンヨウイチヤクソウの全草の水溶性溶媒
抽出物のうち少なくとも1種以上を含有することを特徴
とする化粧料は、安定性の高い美白作用及び抗炎症作用
を併せ持ち、かつ安全性においても好ましいものである
。Effects of the Invention The cosmetic composition of the present invention, which is characterized by containing at least one water-soluble solvent extract of the whole plant of Ichijakakushu, S. japonica, or G. japonica, has a highly stable whitening effect and It has an anti-inflammatory effect and is also preferable in terms of safety.
【0025】以下、実験例を挙げて本発明の効果を説明
する。The effects of the present invention will be explained below with reference to experimental examples.
【0026】有効性試験例1 美白作用チロジナーゼ
活性阻害作用を調べるため、試料の0.15%水溶液に
ついて37℃、2週間の保温処理をする前後のチロジナ
ーゼ活性阻害力を測定した。比較用として、従来より化
粧料として用いられているアスコルビン酸、ヘチマ水お
よびヘチマ果実の熱水抽出物を同様に試験した。なお、
試料は実施例1,2で得られた抽出物を用いた。またヘ
チマの熱水抽出物(比較用)の調製方法としては、乾燥
品10gを熱水抽出(95℃、3時間、300ml)後
、濾液を真空凍結乾燥した。Efficacy Test Example 1 Whitening effect In order to examine the tyrosinase activity inhibition effect, the tyrosinase activity inhibition ability of the 0.15% aqueous solution of the sample was measured before and after being heat-retained at 37°C for 2 weeks. For comparison, ascorbic acid, loofah water, and a hot water extract of loofah fruit, which have been conventionally used as cosmetics, were similarly tested. In addition,
The extracts obtained in Examples 1 and 2 were used as samples. In addition, as a method for preparing a hot water extract of loofah (for comparison), 10 g of the dried product was extracted with hot water (95° C., 3 hours, 300 ml), and the filtrate was freeze-dried in vacuum.
【0027】チロジナーゼ活性阻害作用の測定:試験管
にL−チロシン溶液(0.3mg/ml)を1ml、マ
ックスベイン氏の緩衝液(pH6.8)を1ml、およ
び前記試料の0.15%水溶液0.9mlを加えて、3
7℃の恒温水槽中で10分間インキュベートした。これ
にチロジナーゼ水溶液(1mg/ml)を0.1ml加
えてよく攪拌し、37℃、12分間インキュベート後、
分光光度計にセットして475nmにおける吸光度を測
定した。一方、ブランクとして前記試料の代りに蒸留水
を用いて同様の吸光度測定を行い、各試料のチロジナー
ゼ活性阻害率を下記の式より算出した。なお、式中のA
は各試料を添加した場合の吸光度を、Bはブランクの吸
光度を意味する。
式:阻害率(%)=(1−A/B)×100Measurement of tyrosinase activity inhibition: In a test tube, add 1 ml of L-tyrosine solution (0.3 mg/ml), 1 ml of Max Bain's buffer (pH 6.8), and 0.15% aqueous solution of the above sample. Add 0.9ml, 3
It was incubated for 10 minutes in a constant temperature water bath at 7°C. Add 0.1 ml of tyrosinase aqueous solution (1 mg/ml) to this, stir well, and incubate at 37°C for 12 minutes.
It was set in a spectrophotometer and the absorbance at 475 nm was measured. On the other hand, similar absorbance measurements were performed using distilled water instead of the sample as a blank, and the tyrosinase activity inhibition rate of each sample was calculated using the following formula. In addition, A in the formula
B means the absorbance when each sample is added, and B means the absorbance of the blank. Formula: Inhibition rate (%) = (1-A/B) x 100
【0028
】これらの試験結果を表1に示す。この表から実施例1
,2で得たイチヤクソウもしくはベニバナイチヤクソウ
の全草の水溶性溶媒抽出物は、ヘチマ水およびヘチマの
熱水抽出物よりも顕著なチロジナーゼ活性阻害力を有し
ており、更にこの組成物は熱安定性が良く、37℃、2
週間放置後では、ビタミンCよりも強力なチロジナーゼ
活性阻害力を有していることが認められる。
また、これらの安定性試験により、イチヤクソウもしく
はベニバナイチヤクソウの全草の水溶性溶媒抽出は変臭
、変色が見られなかった。さらに実施例3から5で得ら
れたイチヤクソウ、ベニバナイチヤクソウもしくはジン
ヨウイチヤクソウの全草の水溶性溶媒抽出物も同様に試
験したところ、同程度に良好なチロジナーゼ活性阻害力
を示すことが判った。(以下余白)0028
] The test results are shown in Table 1. Example 1 from this table
, 2, the water-soluble solvent extract of the whole plant of Ichiyakuso or Rubus japonica obtained in 2 has more remarkable tyrosinase activity inhibiting power than loofah water and loofah hot water extract, and furthermore, this composition is thermostable. Good temperature, 37℃, 2
After being left for a week, it was found to have a stronger inhibitory effect on tyrosinase activity than vitamin C. Furthermore, in these stability tests, no odor or discoloration was observed in the water-soluble solvent extraction of the whole plant of Asus japonica or Asus japonica. Furthermore, when the water-soluble solvent extracts of the whole plants of Aspergillus japonica, Aspergillus japonica, or Aspergillus annuus obtained in Examples 3 to 5 were tested in the same manner, it was found that they exhibited similarly good tyrosinase activity inhibition ability. (Margin below)
【0029】[0029]
【表1】[Table 1]
【0030】有効性試験例2 抗炎症作用抗炎症作用
を調べるため、試料を0.01%、0.1%、1.0%
含有する各水溶液について、ヒスタミン遊離抑制試験を
実施した。比較として、従来より化粧料に用いられてい
るヘチマ水およびキダチアロエの熱水抽出物を同様に試
験した。なお、試料は実施例1,2で得られた抽出物を
用いた。またキダチアロエの熱水抽出物(比較用)の調
製方法としては、乾燥品10gを熱水抽出(95℃、3
時間、300ml)後、濾液を真空凍結乾燥した。Efficacy test example 2 Anti-inflammatory effect In order to examine the anti-inflammatory effect, samples were mixed at 0.01%, 0.1%, and 1.0%.
A histamine release inhibition test was conducted for each aqueous solution contained. For comparison, loofah water and a hot water extract of Kidachi aloe, which have been conventionally used in cosmetics, were similarly tested. Note that the extracts obtained in Examples 1 and 2 were used as samples. In addition, as a method for preparing a hot water extract (for comparison) of Kidachialoe, 10 g of the dried product was extracted with hot water (95°C, 3
After 300 ml) the filtrate was lyophilized in vacuo.
【0031】ヒスタミン遊離抑制試験:平井らの報告(
生薬学雑誌、37、374、1983.)に従って、雄
性Spraque−Dawley系ラット(200から
450g)の腹腔内から採取した肥満細胞に対するヒス
タミン遊離抑制作用を測定した。すなわち、4ppmの
コンパウンド48/80によるヒスタミン遊離を抑制す
る作用を遊離抑制率(%)として求めた。結果を表2に
示す。これらの結果から、実施例1,2で得たイチヤク
ソウもしくはベニバナイチヤクソウの全草の熱水抽出物
はヘチマ水およびキダチアロエの熱水抽出物と比較して
、顕著なヒスタミン遊離抑制作用が認められ、抗炎症作
用が優れていることを見出した。また実施例3から5で
得られたイチヤクソウ、ベニバナイチヤクソウもしくは
ジンヨウイチヤクソウの全草の水溶性溶媒抽質物も同様
に試験したところ、良好な抗炎症作用を示すことが判っ
た。(以下余白)[0031] Histamine release inhibition test: Report by Hirai et al. (
Journal of Pharmaceutical Sciences, 37, 374, 1983. ), the inhibitory effect on histamine release on mast cells collected intraperitoneally from male Spraque-Dawley rats (200 to 450 g) was measured. That is, the effect of suppressing histamine release by 4 ppm of compound 48/80 was determined as release inhibition rate (%). The results are shown in Table 2. From these results, it was found that the hot water extract of the whole plant of Ichiyakusou or Rubus japonica obtained in Examples 1 and 2 had a remarkable effect of suppressing histamine release compared to the loofah water and the hot water extract of Kidachialoe. It was found that it has excellent anti-inflammatory effects. Furthermore, the water-soluble solvent extracts of the whole plants of Aspergillus japonica, Rusticum japonica, or Zinja japonica obtained in Examples 3 to 5 were also tested in the same manner, and were found to exhibit good anti-inflammatory effects. (Margin below)
【0032】[0032]
【表2】[Table 2]
【0033】有効性試験例4 使用試験健康な被験者
30名を用いて使用試験を実施した。試料は実施例6お
よび7の化粧料を用い、イチヤクソウもしくはベニバナ
イチヤクソウの全草の水溶性溶媒抽出物の重量%を各々
変化させ用いた。被験者の前腕内側部の2cm平方のサ
イトに、UV−Bランプ(東芝FL−20SE)を用い
、3mW/cm2の強度の紫外線を1分間照射した。各
サイトに先の各試料を3日間毎日朝夕の2回塗布した後
に、炎症の抑制効果をアンケ−ト調査し評価を行った。
1カ月間使用後の色素沈着の抑制効果についてもアンケ
−ト調査を行って評価を行った。なお、紫外線照射した
うちの1サイトは何も塗布しないコントロ−ルとした。
アンケ−トの判定基準は、有効なものを「優」、やや有
効なものを「良」、わずかに有効なものを「可」、無効
なものを「不」とし、コントロ−ルと比較して評価を行
った。Efficacy Test Example 4 Usage Test A usage test was conducted using 30 healthy subjects. As samples, the cosmetics of Examples 6 and 7 were used, and the weight percent of the water-soluble solvent extract of the whole plant of Aspergillus japonica or Asus annuus was varied. A 2 cm square site on the inner side of the subject's forearm was irradiated with ultraviolet light at an intensity of 3 mW/cm 2 for 1 minute using a UV-B lamp (Toshiba FL-20SE). Each sample was applied to each site twice a day in the morning and evening for three days, and then the anti-inflammation effect was evaluated through a questionnaire survey. A questionnaire survey was also conducted to evaluate the pigmentation suppressing effect after one month of use. Note that one site that was irradiated with ultraviolet rays was used as a control in which nothing was applied. The evaluation criteria for the questionnaire was to rate effective items as ``excellent'', somewhat effective items as ``good'', slightly effective items as ``fair'', and ineffective items as ``poor'', and compare them with controls. We conducted an evaluation.
【0034】結果を表4および表5に示す。これらの結
果から、本発明で用いる化粧料は著効な日焼け後の炎症
及び色素沈着の抑制効果を示すことが判る。(以下余白
)The results are shown in Tables 4 and 5. These results show that the cosmetic used in the present invention exhibits a remarkable effect of suppressing post-sunburn inflammation and pigmentation. (Margin below)
【0035】[0035]
【表4】
(以下余白)[Table 4]
(Margin below)
【0036】[0036]
【表5】[Table 5]
【0037】有効性試験例5 安全性試験本発明のイ
チヤクソウの全草の水溶性溶媒抽出物の安全性を明らか
にするため、ヒトに対する一次刺激性試験を閉塞パッチ
テストにより行った。すなわち、フィンチャンバ−(E
PITEST 社製)を用い、健康人30名に対し、前
腕屈側部に48時間閉塞貼付を行い、パッチテスト用絆
創膏除去後、1時間後、24時間後、48時間後の判定
の平均値を用いて判定した。試料は実施例1で得られた
水抽出物を用い、塗布濃度は10%(W/W)水溶液と
し、対照として蒸留水を使用した。判定結果、イチヤク
ソウの全草の水抽出物では全く紅班を認めず、一方、対
照の蒸留水では5名にわずかな紅班を認めた。これらの
結果からイチヤクソウの全草の水抽出物は一次刺激性が
極めて低く、皮膚に対して安全が高いことが確認された
。また、実施例2〜5で得られたイチヤクソウ、ベニバ
ナイチヤクソウもしくはジンヨウイチヤクソウの全草の
の水溶性溶媒抽出物も同様に試験し、皮膚に対して同様
に安全性が高いことが認められた。Efficacy Test Example 5 Safety Test In order to clarify the safety of the water-soluble solvent extract of the whole plant of Ichiyakuso of the present invention, a primary irritation test on humans was conducted by an occlusive patch test. That is, the fin chamber (E
PITEST) was applied to 30 healthy people on the flexor side of the forearm for 48 hours, and the average value of the results 1 hour, 24 hours, and 48 hours after removal of the patch test bandage was calculated. The judgment was made using The water extract obtained in Example 1 was used as a sample, the coating concentration was 10% (W/W) aqueous solution, and distilled water was used as a control. As a result of the evaluation, no erythema was observed in the aqueous extract of the whole plant of Ichiyakusou, while slight erythema was observed in 5 subjects in the case of the control distilled water. These results confirmed that the aqueous extract of the whole plant of Ichiyakusou has extremely low primary irritation and is highly safe for the skin. In addition, the water-soluble solvent extracts of the whole plant of Aspergillus japonica, Ruscus japonica, or Zinja japonica obtained in Examples 2 to 5 were similarly tested and found to be similarly highly safe for the skin. .
Claims (1)
溶媒抽出物を含有することを特徴とする化粧料。1. A cosmetic product containing a water-soluble solvent extract of a whole plant of a plant belonging to the family Alocataceae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3065405A JPH04279511A (en) | 1991-03-05 | 1991-03-05 | Cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3065405A JPH04279511A (en) | 1991-03-05 | 1991-03-05 | Cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04279511A true JPH04279511A (en) | 1992-10-05 |
Family
ID=13286084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3065405A Pending JPH04279511A (en) | 1991-03-05 | 1991-03-05 | Cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04279511A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997004793A1 (en) * | 1995-08-02 | 1997-02-13 | Ingram Teresa J | Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome |
JPH11193212A (en) * | 1997-12-26 | 1999-07-21 | Shiseido Co Ltd | Skin preparation for external use for keeping and enhancing skin ph buffering ability |
JPH11335233A (en) * | 1998-05-22 | 1999-12-07 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor and cosmetic composition |
JP2004168770A (en) * | 2002-10-31 | 2004-06-17 | Ikeda Shokken Kk | Enzyme inhibitor |
-
1991
- 1991-03-05 JP JP3065405A patent/JPH04279511A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997004793A1 (en) * | 1995-08-02 | 1997-02-13 | Ingram Teresa J | Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome |
JPH11193212A (en) * | 1997-12-26 | 1999-07-21 | Shiseido Co Ltd | Skin preparation for external use for keeping and enhancing skin ph buffering ability |
JPH11335233A (en) * | 1998-05-22 | 1999-12-07 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor and cosmetic composition |
JP2004168770A (en) * | 2002-10-31 | 2004-06-17 | Ikeda Shokken Kk | Enzyme inhibitor |
JP4542765B2 (en) * | 2002-10-31 | 2010-09-15 | 池田食研株式会社 | Enzyme inhibitor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2890212B2 (en) | Cosmetics | |
JP3839618B2 (en) | Elastase inhibitor, and anti-aging skin external preparation comprising the same | |
JPH04342519A (en) | Skin cosmetic | |
JPH04346911A (en) | Cosmetic | |
JP3170070B2 (en) | External preparation for skin | |
JPH06199647A (en) | Skin beautifying cosmetic | |
JP2896815B2 (en) | Cosmetics | |
JP5154835B2 (en) | Whitening cosmetics | |
JPH04346912A (en) | Cosmetic | |
JP3010560B2 (en) | Cosmetics | |
JPH04279511A (en) | Cosmetic | |
JP3709363B2 (en) | Melanocyte dendrite elongation inhibitor and cosmetics containing the same | |
JP2003081746A (en) | Extension inhibitor of dendrite of melanocyte and cosmetic containing the same | |
JP2896816B2 (en) | Cosmetics | |
JP5144362B2 (en) | Topical skin preparation | |
JP3027409B2 (en) | Cosmetics | |
JPH01139517A (en) | Cosmetic | |
JP2896814B2 (en) | Cosmetics | |
JPH0665045A (en) | Skin external preparation | |
JPH10120546A (en) | Skin whitening preparation for external use | |
JP2001131079A (en) | Skin preparation for external use | |
JP2002068956A (en) | Skin cosmetic | |
KR100654959B1 (en) | The cosmetic composition for skin whitening | |
JPH05320034A (en) | Cosmetic | |
JPH04356416A (en) | Skin cosmetic |